Vaishali Pharma has entered into licensing agreement with U.S.A. Healthcare Market for the Healthcare Products. Exposure to International Market in catering Quality Products, has fetch a new set of business for company from U.S.A. Healthcare Market. Initially 5 Products have been finalized to be sourced for the U.S.A. Healthcare Market as per the In Licensing Agreement for the Healthcare Products.
The Company is striving hard to double the product range in various countries in coming years and working in that direction consistently.
Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets.
| Company Name | CMP |
|---|---|
| Redington | 227.35 |
| Adani Enterprises | 2225.25 |
| Amrapali Industries | 17.27 |
| Rashi Peripheral | 474.40 |
| PDS | 291.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: